What is Melodiol Global Health Price-to-Operating-Cash-Flow?
As of today (2024-06-09), Melodiol Global Health's share price is A$0.39.
Melodiol Global Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.02. Hence, Melodiol Global Health's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Melodiol Global Health's Price-to-Operating-Cash-Flow or its related term are showing as below:
Melodiol Global Health's Cash Flow from Operations per share for the
six
months ended in Dec. 2023 was A$-0.40.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.02.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 51.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 46.20% per year.
During the past 8 years, Melodiol Global Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.70% per year. The lowest was 4.30% per year. And the median was 34.70% per year.
Melodiol Global Health Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Melodiol Global Health's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Melodiol Global Health Price-to-Operating-Cash-Flow Chart
|
Melodiol Global Health Annual Data
|
|
Trend |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
- |
- |
- |
- |
|
Melodiol Global Health Semi-Annual Data
|
|
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Melodiol Global Health's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Melodiol Global Health's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Melodiol Global Health's Price-to-Operating-Cash-Flow falls into.
Melodiol Global Health Price-to-Operating-Cash-Flow Calculation
Melodiol Global Health's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.39 | / | -2.017 |
| = | |
Melodiol Global Health's Share Price of today is A$0.39.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Melodiol Global Health's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Melodiol Global Health (ASX:ME1DE) Business Description
Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.
Melodiol Global Health (ASX:ME1DE) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:ME1DE has been successfully added to your